BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21641401)

  • 1. Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age.
    de Oliveira Gomes A; de Oliveira Silva DA; Silva NM; de Freitas Barbosa B; Franco PS; Angeloni MB; Fermino ML; Roque-Barreira MC; Bechi N; Paulesu LR; Dos Santos MC; Mineo JR; Ferro EA
    Am J Pathol; 2011 Jun; 178(6):2792-801. PubMed ID: 21641401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants.
    Ferro EA; Mineo JR; Ietta F; Bechi N; Romagnoli R; Silva DA; Sorda G; Bevilacqua E; Paulesu LR
    Am J Pathol; 2008 Jan; 172(1):50-8. PubMed ID: 18165264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of macrophage migration inhibitory factor and CD74 in preeclamptic placenta and its correlation with preeclampsia].
    Xie XF; Zhan Y; Ye YH; Li C; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):278-82. PubMed ID: 20646540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Macrophage Migration Inhibitory Factor (MIF) in the survival of first trimester human placenta under induced stress conditions.
    Ietta F; Ferro EAV; Bevilacqua E; Benincasa L; Maioli E; Paulesu L
    Sci Rep; 2018 Aug; 8(1):12150. PubMed ID: 30108299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrofloxacin and Toltrazuril Are Able to Reduce
    da Silva RJ; Gomes AO; Franco PS; Pereira AS; Milian ICB; Ribeiro M; Fiorenzani P; Dos Santos MC; Mineo JR; da Silva NM; Ferro EAV; de Freitas Barbosa B
    Front Cell Infect Microbiol; 2017; 7():340. PubMed ID: 28798905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A1 peptide is able to induce an anti-parasitic effect in human placental explants infected by Toxoplasma gondii.
    de Oliveira Cardoso MF; Moreli JB; Gomes AO; de Freitas Zanon C; Silva AE; Paulesu LR; Ietta F; Mineo JR; Ferro EA; Oliani SM
    Microb Pathog; 2018 Oct; 123():153-161. PubMed ID: 30003946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brazilian strains of Toxoplasma gondii are controlled by azithromycin and modulate cytokine production in human placental explants.
    Franco PS; Gois PSG; de Araújo TE; da Silva RJ; de Freitas Barbosa B; de Oliveira Gomes A; Ietta F; Dos Santos LA; Dos Santos MC; Mineo JR; Ferro EAV
    J Biomed Sci; 2019 Jan; 26(1):10. PubMed ID: 30665403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection.
    Marcon CF; Ferreira PTM; Franco PS; Ribeiro M; Silva RJ; Sousa RAP; Oliveira CJF; Rodrigues Junior V; Gomes MLM; Lazo Chica JE; Mineo TWP; Mineo JR; Barbosa BF; Ferro EAV; Gomes AO
    Cytokine; 2020 Dec; 136():155283. PubMed ID: 32947151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Migration Inhibitory Factor contributes to drive phenotypic and functional macrophages activation in response to Toxoplasma gondii infection.
    Ferreira PTM; Oliveira-Scussel ACM; Sousa RAP; Gomes BQ; Félix JE; Silva RJ; Millian IB; Assunção TSF; Teixeira SC; Gomes MLM; Silva MV; Barbosa BF; Rodrigues Junior V; Mineo JR; Oliveira CJF; Ferro EAV; Gomes AO
    Immunobiology; 2023 May; 228(3):152357. PubMed ID: 36857907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIF participates in Toxoplasma gondii-induced pathology following oral infection.
    Cavalcanti MG; Mesquita JS; Madi K; Feijó DF; Assunção-Miranda I; Souza HS; Bozza MT
    PLoS One; 2011; 6(9):e25259. PubMed ID: 21977228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NADPH oxidase 4 is required for the generation of macrophage migration inhibitory factor and host defense against Toxoplasma gondii infection.
    Kim JH; Lee J; Bae SJ; Kim Y; Park BJ; Choi JW; Kwon J; Cha GH; Yoo HJ; Jo EK; Bae YS; Lee YH; Yuk JM
    Sci Rep; 2017 Jul; 7(1):6361. PubMed ID: 28743960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasma gondii: impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection.
    Terrazas CA; Juarez I; Terrazas LI; Saavedra R; Calleja EA; Rodriguez-Sosa M
    Exp Parasitol; 2010 Nov; 126(3):348-58. PubMed ID: 20331989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.
    Ohta S; Misawa A; Fukaya R; Inoue S; Kanemura Y; Okano H; Kawakami Y; Toda M
    J Cell Sci; 2012 Jul; 125(Pt 13):3210-20. PubMed ID: 22454509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to Toxoplasma gondii proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via ERK1/2 phosphorylation and prostaglandin E2 production.
    Barbosa BF; Paulesu L; Ietta F; Bechi N; Romagnoli R; Gomes AO; Favoreto-Junior S; Silva DA; Mineo JR; Mineo TW; Ferro EA
    Placenta; 2014 Mar; 35(3):152-62. PubMed ID: 24433846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17{beta}-Estradiol modulates the macrophage migration inhibitory factor secretory pathway by regulating ABCA1 expression in human first-trimester placenta.
    Ietta F; Bechi N; Romagnoli R; Bhattacharjee J; Realacci M; Di Vito M; Ferretti C; Paulesu L
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E411-8. PubMed ID: 20173014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury.
    Zhou Y; Guo W; Zhu Z; Hu Y; Wang Y; Zhang X; Wang W; Du N; Song T; Yang K; Guan Z; Wang Y; Guo A
    J Neuroinflammation; 2018 Sep; 15(1):253. PubMed ID: 30180853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BjussuLAAO-II, an l-amino acid oxidase from Bothrops jararacussu snake venom, impairs Toxoplasma gondii infection in human trophoblast cells and villous explants from the third trimester of pregnancy.
    de Melo Fernandes TA; Teixeira SC; Costa TR; Rosini AM; de Souza G; Polloni L; Barbosa BF; Silva MJB; Ferro EAV; Ávila VMR
    Microbes Infect; 2023; 25(6):105123. PubMed ID: 36870599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex.
    Gore Y; Starlets D; Maharshak N; Becker-Herman S; Kaneyuki U; Leng L; Bucala R; Shachar I
    J Biol Chem; 2008 Feb; 283(5):2784-92. PubMed ID: 18056708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative ex vivo infection with Trypanosoma cruzi and Toxoplasma gondii of human, canine and ovine placenta: Analysis of tissue damage and infection efficiency.
    Liempi A; Castillo C; Medina L; Galanti N; Maya JD; Parraguez VH; Kemmerling U
    Parasitol Int; 2020 Jun; 76():102065. PubMed ID: 32001348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
    Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
    World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.